PM interacts with leaders of pharma industry

PM Modi appreciated the way the pharma industry is working even in such trying conditions

The Prime Minister, Narendra Modi interacting with the Representatives from Pharma Industry, through video conferencing, in New Delhi on April 19, 2021.
New Delhi: During his interaction with the leaders of the pharmaceutical industry via video conferencing on 19th April, Prime Minister Narendra Modi lauded the crucial role of the sector in the fight against the COVID-19 pandemic.
PM Modi appreciated the way the pharma industry is working even in such trying conditions.
PM Modi remarked that it is because of the efforts of the pharma industry that today India is identified as the ‘pharmacy of the world’. He said essential medicines were made available to more than 150 countries around the world during the pandemic. The Prime Minister stated that despite all the challenges, the Indian pharma industry has also registered a growth of 18 percent in exports last year, which shows its potential.
Noting the second wave of the virus and the rising number of cases, PM Modi commended the pharma industry for their efforts to increase the production of several necessary drugs. He appreciated them for reducing the price of injections like Remdesivir. To keep the supply of medicines and essential medical equipment going smoothly, PM Modi urged the pharma industry to ensure seamless supply chains. PM Modi also extended the government’s support for facilities like Logistics and Transportation.
He urged the industry to conduct more and more researches on threats that can occur in the future along with Covid. This, he said, would help us take the lead in combating the virus.
Seeking cooperation from the pharma industry, PM Modi assured that the government is undertaking reforms for new drugs and regulatory processes.
The leaders of the Pharma industry appreciated the proactive help and support received from the Government. They highlighted the efforts made over the last year in ensuring the availability of drugs keeping manufacturing and logistics operations. Operations at the pharma hubs for manufacturing, transportation, logistics, and ancillary services are being maintained at optimum levels. The participants also share inputs on the measures being undertaken to meet the overall medicine demand in the country despite the unprecedented increase in demand for some drugs the COVID Treatment Protocol.